Brief: Paratek Pharmaceuticals - On July 14 Entered Into A Supply Agreement With Carbogen Amcis AG
July 14 (Reuters) - Paratek Pharmaceuticals Inc PRTK.O :
* PARATEK PHARMACEUTICALS - ON JULY 14 ENTERED INTO A SUPPLY
AGREEMENT WITH CARBOGEN AMCIS AG
* PARATEK PHARMACEUTICALS - UNDER AGREEMENT CARBOGEN TO
MAKE,
SUPPLY TO CO ACTIVE PHARMACEUTICAL INGREDIENT FOR OMADACYCLINE
PRODUCT IN BULK QUANTITIES
* PARATEK PHARMACEUTICALS - OBLIGATED TO INITIALLY PAY
CARBOGEN
AMOUNT IN HIGH SIX-DIGIT U.S. DOLLAR RANGE PER BATCH OF CARBOGEN
PRODUCT THAT CO ORDERS
Source text: https://bit.ly/2VI0CRw
Further company coverage: PRTK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million